VOYA Investment Management
AZN icon

VOYA Investment Management’s AstraZeneca AZN Stock Holding History

VOYA Investment Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$233M Sell
1,233,595
-636,269
-34% -$120M 0.2% 127
2026
Q1 		$368M Buy
1,869,864
+533,781
+40% +$103M 0.38% 60
2025
Q4 		$246M Buy
1,336,083
+386,332
+41% +$67.8M 0.24% 91
2025
Q3 		$146M Buy
949,751
+385,208
+68% +$58.3M 0.15% 154
2025
Q2 		$78.9M Sell
564,543
-539,010
-49% -$75.5M 0.08% 250
2025
Q1 		$162M Buy
1,103,553
+221,898
+25% +$32.1M 0.18% 137
2024
Q4 		$116M Sell
881,655
-1,639,074
-65% -$229M 0.12% 191
2024
Q3 		$393M Sell
2,520,729
-133,129
-5% -$21.5M 0.41% 43
2024
Q2 		$414M Buy
2,653,858
+816,507
+44% +$123M 0.41% 41
2024
Q1 		$249M Buy
1,837,351
+209,270
+13% +$27.7M 0.24% 97
2023
Q4 		$219M Sell
1,628,081
-146,938
-8% -$19.1M 0.23% 102
2023
Q3 		$240M Buy
1,775,019
+1,349,787
+317% +$184M 0.27% 84
2023
Q2 		$60.9M Sell
425,232
-33,398
-7% -$4.91M 0.06% 296
2023
Q1 		$63.7M Sell
458,630
-22,020
-5% -$2.96M 0.07% 298
2022
Q4 		$65.2M Sell
480,650
-58,437
-11% -$7.33M 0.08% 294
2022
Q3 		$59.1M Buy
+539,087
New +$68.4M 0.07% 289
2021
Q3 		– Sell
-475,206
Closed -$56.9M – 2807
2021
Q2 		$56.9M Buy
+475,206
New +$52.1M 0.11% 189
2018
Q3 		– Sell
-323,188
Closed -$22.7M – 2585
2018
Q2 		$22.7M Sell
323,188
-960,372
-75% -$69.1M 0.05% 404
2018
Q1 		$89.8M Sell
1,283,560
-10,461
-0.8% -$725K 0.19% 124
2017
Q4 		$89.8M Buy
1,294,021
+347,345
+37% +$23.4M 0.19% 119
2017
Q3 		$64.1M Sell
946,676
-251,057
-21% -$15.9M 0.14% 163
2017
Q2 		$81.7M Buy
1,197,733
+331,241
+38% +$21.6M 0.18% 125
2017
Q1 		$54M Sell
866,492
-11,703
-1% -$681K 0.12% 165
2016
Q4 		$48M Buy
878,195
+205,158
+30% +$11.6M 0.11% 175
2016
Q3 		$44.2M Sell
673,037
-486,105
-42% -$31.8M 0.08% 191
2016
Q2 		$70M Buy
1,159,142
+664,117
+134% +$38.6M 0.17% 132
2016
Q1 		$27.9M Buy
+495,025
New +$29.7M 0.07% 267

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

VOYA Investment Management's AZN Position: Q2 2026 in Review

VOYA Investment Management reduced its AstraZeneca (AZN) stake by 34% in Q2 2026, selling an estimated $120M and leaving 1,233,595 shares worth $233M. The position accounts for 0.2% of the portfolio, ranked #127.

VOYA Investment Management first reported a position in AZN in Q1 2016 and has held it in 27 quarters since. The position peaked at $414M in Q2 2024. 1,498 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • VOYA Investment Management held 1,233,595 shares of AstraZeneca worth $233M as of Q2 2026.
  • VOYA Investment Management sold 636,269 AstraZeneca shares in Q2 2026, an estimated $120M.
  • AstraZeneca made up 0.2% of VOYA Investment Management's portfolio in Q2 2026, its #127 holding.
  • VOYA Investment Management first reported a position in AstraZeneca in Q1 2016 and has held it in 27 quarters since.
  • VOYA Investment Management's AstraZeneca position peaked at $414M in Q2 2024.
  • 1,498 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.